Recognize threatened bowel before peritonitis, read arterial and venous CTA, and match reperfusion, anticoagulation, or surgery to cause and viability.
Severe abdominal pain with little tenderness can be the presentation of bowel ischemia while the bowel is still salvageable. Waiting for rigidity, a high lactate, or obvious intestinal gas abnormalities can turn a diagnostic opportunity into irreversible tissue loss.
Acute mesenteric ischemia asks two separate questions. Why is blood flow failing, and how much bowel remains viable? The first selects a vascular treatment. The second determines whether the patient also needs an operation.
The quiet abdomen can be an early warning
Acute mesenteric ischemia means an abrupt mismatch between intestinal oxygen supply and demand severe enough to threaten tissue. It can result from arterial inflow obstruction, venous outflow obstruction, or inadequate perfusion despite patent major vessels. Early mucosal and visceral injury can produce intense pain before inflammation reaches the parietal peritoneum. This creates the classic pain out of proportion to examination. It is a reason to suspect ischemia, not a rule that must be present in every patient. [1]
Risk context gives an otherwise nonspecific pain report meaning. Atrial fibrillation, a recent myocardial infarction with ventricular thrombus, or another cardiac embolic source raises concern for arterial embolism. Months of postprandial pain, food avoidance, weight loss, and atherosclerosis suggest limited mesenteric reserve before an acute thrombosis. Shock, low cardiac output, severe dehydration, and vasopressor dependence raise concern for nonocclusive mesenteric ischemia. Venous thrombosis has a different context, including local inflammation, malignancy, and persistent or transient prothrombotic states. [1][2]
Vomiting, diarrhea, or blood in stool may occur. None safely excludes a vascular emergency. A sedated or ventilated patient may not report pain at all; unexplained distention, feeding intolerance, gastrointestinal bleeding, or worsening organ dysfunction may be the first signal. Isolated right-sided colonic ischemia or an atypical pain pattern should also keep a more extensive mesenteric process in consideration. [1]
Lactate cannot grant clearance
A normal lactate does not exclude early ischemia. A raised lactate may come from systemic shock, dehydration, impaired clearance, or another process, so it does not identify the blocked vessel or independently prove bowel necrosis. Leukocytosis, metabolic acidosis, and D-dimer have similar limits. Obtain useful blood tests, but do not make their return a prerequisite for CTA when suspicion is meaningful. Trends help assess physiology after treatment; they do not replace reassessing the abdomen and perfusion. [1][2]
Locate inflow failure, outflow failure, or low flow
The superior mesenteric artery, or SMA, supplies most small bowel beyond the proximal duodenum and the right colon through the proximal transverse colon. The celiac system supplies foregut organs, while the inferior mesenteric artery supplies more distal colon and upper rectal territory. Collateral networks can support neighboring beds, but an acute SMA occlusion can threaten extensive intestine before collaterals compensate. Distribution depends on lesion level, branch anatomy, and pre-existing collateral flow. [2]
Intestinal circulation has an entry side and an exit side
Aorta → SMA → intestinal arterial branches. An embolus or thrombosis here reduces inflow.
Small arteries → intestinal capillary bed. Shock and intense vasoconstriction can impair tissue perfusion even when the proximal SMA is open.
Intestinal veins → superior mesenteric vein → portal circulation. Venous thrombosis raises downstream pressure, producing congestion, edema, and eventually reduced effective perfusion.
The superior mesenteric vein joins the splenic vein to form the portal vein. This flow diagram is schematic; it does not depict individual anatomic variants. Venous thrombosis is not a clot inside the SMA.
Arterial embolism
A clot arrives from elsewhere, often the heart. Abrupt severe pain and a focal SMA defect beyond the origin fit this mechanism. Other organ emboli may coexist. The SMA origin may remain open.
Arterial thrombosis
Clot forms on diseased artery, commonly near an atherosclerotic origin. Prior intestinal angina and ostial plaque favor acute-on-chronic inflow failure. This may require treating the underlying stenosis as well as thrombus.
Nonocclusive mesenteric ischemia
NOMI reflects low flow and vasoconstriction without a large-vessel plug. A patent SMA does not prove the intestinal microcirculation is adequately perfused.
Mesenteric venous thrombosis
MVT impedes outflow. Pain may develop less abruptly, and bowel-wall edema can be prominent. A venous filling defect identifies a different treatment target from an arterial cutoff.
These are probability patterns, not absolute diagnostic labels. Atrial fibrillation does not make every abdominal complaint an embolus, and absence of known arrhythmia does not exclude embolism. The vascular study must establish which mechanism fits. [1][2]
Read the CTA in two passes
Request urgent CT angiography of the abdomen and pelvis with arterial and venous phases, and explicitly tell radiology that mesenteric ischemia is suspected. Routine noncontrast CT cannot adequately answer the vascular question. Oral contrast is unnecessary and can delay assessment. Current ESVS guidance recommends appropriate CTA regardless of renal function when acute mesenteric ischemia is suspected, because the danger of diagnostic delay outweighs the contrast concern in this emergency. This does not eliminate thoughtful resuscitation and renal care. [1][2]
First pass through the vessels
Identify the lesion location, length, and branch involvement. A focal distal arterial filling defect suggests embolism. An ostial occlusion with calcified plaque suggests thrombosis on chronic disease. Inspect the mesenteric and portal veins rather than stopping when the arteries look open. In NOMI, proximal vessels may be patent while branch narrowing and abnormal bowel enhancement accompany the low-flow clinical setting. CTA can also reveal alternative diagnoses or simultaneous embolic injury elsewhere. [2]
Second pass through the bowel and peritoneum
Ask whether bowel enhances, whether it is thickened or dilated, and whether there is pneumatosis, portomesenteric venous gas, free fluid, or free air. Reduced or absent enhancement is concerning for ischemia. An occluded vessel with preserved bowel enhancement still needs urgent treatment but does not prove transmural necrosis. Pneumatosis means gas in the bowel wall; its cause is not always irreversible ischemia. Interpret it with enhancement, physiology, vascular findings, and examination. Portal venous gas with shock and nonenhancing bowel is much more concerning than an isolated gas finding in a well patient. [1][4]
Threatened bowel and dead bowel are not interchangeable. Severe pain with a soft abdomen can precede infarction. Peritonitis, perforation, and deteriorating physiology demand operative assessment; they should not be awaited as diagnostic proof.
No imaging sign perfectly determines viability in every segment. Surgical assessment may still be necessary even after a vascular lesion has been treated. Conversely, bowel that initially looks marginal can recover after blood flow and physiology improve. [1]
Treat the mechanism while protecting remaining bowel
Involve emergency surgery, vascular surgery, interventional expertise, anesthesia, and critical care according to local resources. Resuscitation and diagnosis proceed together. Correct hypovolemia, oxygenation problems, electrolyte derangements, and acid-base disturbances. Avoid indiscriminate fluid loading that worsens bowel edema and abdominal pressure. Keep the patient without oral intake; nasogastric decompression may help vomiting or distention. Broad-spectrum antibiotics are given early because ischemic mucosal barrier failure permits bacterial translocation, even before a free perforation is demonstrated. [1]
Arterial occlusion
Urgent restoration of arterial flow is central when salvageable bowel remains. Endovascular aspiration, thrombectomy, stenting, or selected thrombolysis may be appropriate when expertise and anatomy permit and there is no indication for immediate bowel exploration. Open embolectomy or bypass and hybrid approaches remain important. An embolus and an ostial atherosclerotic occlusion may need different techniques. Therapeutic unfractionated heparin is commonly used unless contraindicated, but anticoagulation alone is not definitive treatment for an occluded artery threatening viable bowel. [1][3]
Venous thrombosis
MVT without peritonitis is usually treated with therapeutic anticoagulation and close inpatient assessment. Unfractionated heparin is useful when renal failure, rapid reversal, or a possible procedure makes titration important. Stable venous disease does not automatically need arterial revascularization or bowel resection. Deterioration despite anticoagulation requires renewed assessment of viability and possible intervention; peritonitis requires surgery regardless of the original venous mechanism. [1][2]
NOMI
Correct the cause of inadequate perfusion, including volume depletion, low cardiac output, sepsis, and excessive vasoconstriction where feasible. Do not abruptly stop life-sustaining vasopressors without supporting circulation. Reassess the hemodynamic strategy with critical care. Selected patients may receive catheter-directed vasodilator therapy such as papaverine. ESVS grades this as a may-be-considered option (class IIb, level C); evidence is limited, and treatment requires specialist monitoring because systemic hypotension can occur. This is not a substitute for resecting infarcted bowel, and it is not treatment for a mesenteric venous thrombus. [1][2]
For any mechanism, generalized peritonitis or perforation calls for prompt operative exploration with resection of clearly nonviable tissue and restoration of flow when feasible. Reperfusion cannot make dead perforated bowel safe, and resection alone does not solve an untreated arterial inflow problem. [1]
Reassess viability and prevent the next event
When bowel viability remains uncertain after revascularization, a damage-control approach may preserve options. Clearly necrotic segments are resected, uncertain bowel is reassessed after physiologic stabilization, and an anastomosis may be deferred when edema or shock makes it unsafe. A planned second-look operation, often within 24 to 48 hours, can distinguish recovering tissue from bowel that has declared irreversible injury. The objective is to preserve useful length without leaving necrosis behind. [1]
Extensive resection can produce short bowel syndrome, with fluid and electrolyte losses and impaired nutrient absorption. Remaining length, terminal ileum, ileocecal valve, and colon continuity affect the rehabilitation plan. Some patients need parenteral support and an intestinal rehabilitation team. The possibility of profound long-term intestinal failure belongs in operative goals-of-care discussions when extensive nonviability is discovered. [1][2]
Prevention follows the cause. A cardiac embolic source needs appropriate long-term embolic prevention. Atherosclerotic disease needs vascular risk treatment and surveillance after revascularization. MVT requires a duration plan based on provocation, persistent thrombophilia, bleeding risk, and recurrence. ESVS recommends three to six months of anticoagulation for acute MVT, with reassessment for longer treatment. Extended treatment beyond six months should be considered even after a transient trigger, balancing recurrence against bleeding risk. Idiopathic disease or permanent risk factors generally warrants indefinite treatment with ongoing review. Do not stop anticoagulation simply because pain resolves. [2]
Suspect a vascular cause from pain and risk context, even with normal lactate.
Use arterial and venous CTA to identify mechanism and threatened tissue.
Restore arterial inflow, anticoagulate venous thrombosis, or correct low flow according to cause.
Operate for peritonitis or nonviable bowel and reassess uncertain segments.
Link discharge prevention to the mechanism that caused the event.
Decide what the vessel and bowel each require
Case 1
Show answer and explanations for case 1
A. Urgent arterial and venous phase CT angiography (Best answer)
The pain-risk combination warrants vessel and bowel assessment despite normal lactate.
B. Repeat lactate before deciding about imaging (Why this does not fit)
An early normal value cannot exclude threatened bowel.
C. Noncontrast CT as the definitive vascular study (Why this does not fit)
It cannot adequately establish mesenteric vessel patency and enhancement.
D. Colonoscopy before vascular imaging (Why this does not fit)
The suspected acute mesenteric vascular problem requires CTA; colonoscopy delays that assessment.
Takeaway: Clinical suspicion, not lactate, triggers CTA.
A. Stop after an early follow-up scan shows partial recanalization (Why this does not fit)
Early imaging improvement does not substitute for an adequate therapeutic course.
B. Require lifelong treatment solely because the thrombosis involved a mesenteric vein (Why this does not fit)
Duration depends on provocation, recurrence, persistent risks and bleeding risk; every provoked event does not mandate lifelong therapy.
C. Continue a three-to-six-month initial course and reassess treatment beyond six months (Best answer)
ESVS recommends three to six months initially and consideration of extended therapy even with a transient trigger, after balancing recurrence and bleeding risks. Ten days is inadequate despite symptom relief.
D. Stop once abdominal pain resolves (Why this does not fit)
Symptom resolution can precede adequate treatment of the clot and recurrence risk.
Takeaway: Anticoagulation duration follows thrombotic risk, not pain duration.
